NCT04627155View on ClinicalTrials.gov

A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 15, 2013

Primary Completion Date

May 20, 2013

Study Completion Date

May 20, 2013

Conditions
Parkinson Disease
Interventions
DRUG

LY03003

Rotigotine,extended-release microspheres

All Listed Sponsors
lead

Luye Pharma Group Ltd.

INDUSTRY

NCT04627155 - A Study to Evaluate the Human Tolerance and Pharmacokinetics of LY03003 | Biotech Hunter | Biotech Hunter